A drug patent lawyer says a Pacific-wide trade agreement to keep the protection period for new generation biological drugs at five years is good news for New Zealand's healthcare bill, if accurate.
Show status: Off air
Recent stories from Checkpoint
Get the RNZ app
for easy access to all your favourite programmes
